Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of Deep IL-15 primed T cells

Trial Profile

A clinical trial of Deep IL-15 primed T cells

Planning
Phase of Trial: Phase I/II

Latest Information Update: 04 Feb 2019

At a glance

  • Drugs Deep IL-15 primed T cells (Primary)
  • Indications Cancer; Haematological malignancies; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Feb 2019 According to a Torque Therapeutics media release, this trial is expected to begin in the first quarter of 2019.
    • 25 Jan 2019 According to a Torque Therapeutics media release, this trial is expected to begin in early 2019.
    • 29 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top